InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
2
T+90 hit rate
0%
T+90 mean return
-43.9%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Pandite Arundathy N., Chief Medical Officer. Director active across 2 companies, notably Shattuck Labs, Inc.. Aggregated, 12 reports have been published. Split: 0 buy · 2 sells. Total volume traded: €338k. Activity tracked since 10 August 2021. The latest transaction was disclosed on 12 May 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations12 total
30,000 shares@ US$6.610.035% mcap100.0% of flowCommon StockSEC:0001193125-26-224669:0
30,000 shares@ US$6.610.073% mcap100.0% of flowCommon StockSEC:0001193125-26-224669
3,211 shares@ US$1.161.7% of flowCommon StockSEC:0000950170-25-010004:0
6,884 shares@ US$1.193.7% of flowCommon StockSEC:0000950170-25-004939:0
2,920 shares@ US$9.9912.5% of flowCommon StockSEC:0000950170-24-009382:0
46,475 shares0Common StockSEC:0000950170-24-004648:0
37,875 shares0Common StockSEC:0000899243-23-002884:0
2,987 shares@ US$3.033.9% of flowCommon StockSEC:0000899243-23-001683:0
34,738 shares0Common StockSEC:0000899243-22-001797
34,738 shares0Common StockSEC:0000899243-22-001797:0
4,259 shares@ US$0.010.0000% mcap0.0% of flowCommon StockSEC:0000899243-21-032549:0
4,259 shares@ US$0.010.0% of flowCommon StockSEC:0000899243-21-032549
12 of 12 declarations
About Pandite Arundathy N.
Arundathy N. Pandite is the Chief Medical Officer at Shattuck Labs, Inc. She is responsible for the medical strategy and innovation within the company. Shattuck Labs focuses on developing advanced therapies. Arundathy plays a key role in guiding medical research and development initiatives.
